A Patient With Metastatic Sarcoma was Successfully Treated With Radiolabeled Somatostatin Analogs.
Clin Nucl Med
; 41(9): 705-7, 2016 Sep.
Article
en En
| MEDLINE
| ID: mdl-27355848
ABSTRACT
We present a sarcoma patient with a tumor reduction of more than 50% in lung metastasis after 2 single courses of the investigational medical product Lutathera (Lu-DOTA0-Tyr3-octreotate). She was resistant to more than 6 lines of therapy including all the available active drugs in soft tissue sarcomas. The high expression of somatostatin receptors was shown by microarrays and Octreoscan. The overall duration of response exceeded 1 year.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Octreótido
/
Sarcoma Sinovial
/
Neoplasias Pulmonares
/
Antineoplásicos
Límite:
Adult
/
Female
/
Humans
Idioma:
En
Revista:
Clin Nucl Med
Año:
2016
Tipo del documento:
Article